Literature DB >> 5491259

Ectopic secretion of parathyroid hormone by a renal adenocarcinoma in a patient with hypercalcaemia.

R M Buckle, M McMillan, C Mallinson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5491259      PMCID: PMC1820326          DOI: 10.1136/bmj.4.5737.724

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  7 in total

1.  Hypercalcemia in malignant disease without evidence of bone destruction.

Authors:  A GELLHORN; C H PLIMPTON
Journal:  Am J Med       Date:  1956-11       Impact factor: 4.965

2.  Hypercalcemia in osteolytic metastatic cancer of the breast.

Authors:  A J SWYER; J S BERGER; H M GORDON; D LASZLO
Journal:  Am J Med       Date:  1950-06       Impact factor: 4.965

Review 3.  Parathyroid hormone: chemical properties and structural requirements for biological and immunological activity.

Authors:  J T Potts; G D Aurbach; L M Sherwood
Journal:  Recent Prog Horm Res       Date:  1966

4.  Evidence for parathyroid hormone in nonparathyroid tumors associated with hypercalcemia.

Authors:  P L Munson; A H Tashjian; L Levine
Journal:  Cancer Res       Date:  1965-08       Impact factor: 12.701

5.  Production of parathyroid hormone by nonparthyroid tumors.

Authors:  L M Sherwood; J L O'Riordan; G D Aurbach; J T Potts
Journal:  J Clin Endocrinol Metab       Date:  1967-01       Impact factor: 5.958

6.  Radioimmunoassay of parathyroid hormone in primary hyperparathyroidism: studies after removal of parathyroid adenoma.

Authors:  R M Buckle
Journal:  Br Med J       Date:  1969-06-28

7.  IMMUNOCHEMICAL IDENTIFICATION OF PARATHYROID HORMONE IN NON-PARATHYROID NEOPLASMS ASSOCIATED WITH HYPERCALCEMIA.

Authors:  A H TASHJIAN; L LEVINE; P L MUNSON
Journal:  J Exp Med       Date:  1964-03-01       Impact factor: 14.307

  7 in total
  13 in total

1.  How is renal carcinoma detected?

Authors:  L Ekelund; K Jonsson
Journal:  Int Urol Nephrol       Date:  1977       Impact factor: 2.370

2.  Hypercalcemia and urinary excretion of cyclic AMP in bronchogenic carcinoma.

Authors:  G Francini; M Galli
Journal:  World J Surg       Date:  1977-07       Impact factor: 3.352

Review 3.  Role of prostaglandins in bone metabolism: a review.

Authors:  D Atkins; M Greaves; K J Ibbotson; T J Martin
Journal:  J R Soc Med       Date:  1979-01       Impact factor: 5.344

Review 4.  Rare and changeable as a chameleon: paraneoplastic syndromes in renal cell carcinoma.

Authors:  M Hegemann; N Kroeger; A Stenzl; J Bedke
Journal:  World J Urol       Date:  2018-02-10       Impact factor: 4.226

5.  Pancreatic endocrine carcinoma with ectopic PTH-production and paraneoplastic hypercalcaemia.

Authors:  H Arps; M Dietel; A Schulz; H Janzarik; G Klöppel
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

Review 6.  Tumour-associated hormonal products.

Authors:  J Landon; J G Ratcliffe; L H Rees; A P Scott
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

7.  Criteria for development of animal models of diseases of the endocrine system.

Authors:  C C Capen
Journal:  Am J Pathol       Date:  1980-12       Impact factor: 4.307

8.  Immune suppression, gliomas, and tuberculosis.

Authors: 
Journal:  Br Med J       Date:  1972-02-05

9.  Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma.

Authors:  Ganesh S Palapattu; Blaine Kristo; Jacob Rajfer
Journal:  Rev Urol       Date:  2002

Review 10.  Malignant disease of the kidney. An appraisal of diagnosis and management.

Authors:  G D Chisholm
Journal:  Ann R Coll Surg Engl       Date:  1974-07       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.